0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 41-60 of 174 Articles
Editorial |  FREE
Eric D. Peterson, MD, MPH; J. Michael Gaziano, MD; Philip Greenland, MD
JAMA. 2014;311(5):474-476. doi:10.1001/jama.2013.284430.

JAMA Revisited | 
JAMA. 2014;311(4):423. doi:10.1001/jama.2013.279299.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(4):349. doi:10.1001/jama.2014.61.

Original Investigation |  FREE
Leonard V. Sacks, MBBCh; Hala H. Shamsuddin, MD; Yuliya I. Yasinskaya, MD; et al.
JAMA. 2014;311(4):378-384. doi:10.1001/jama.2013.282542.
Includes: CME, Supplemental Content

JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2014;311(3):321. doi:10.1001/jama.2013.283505.
Includes: Supplemental Content

Original Investigation |  FREE
Stephen J. Nicholls, MBBS, PhD; John J. P. Kastelein, MD, PhD; Gregory G. Schwartz, MD, PhD; et al.
JAMA. 2014;311(3):252-262. doi:10.1001/jama.2013.282836.
Includes: Supplemental Content

Original Investigation |  FREE
Sonja Gandhi, BSc; Jamie L. Fleet, BHSc; David G. Bailey, BScPhm, PhD; et al.
JAMA. 2013;310(23):2544-2553. doi:10.1001/jama.2013.282426.
Includes: Supplemental Content

Original Investigation |  FREE
Jameson R. Lam, MPH; Jennifer L. Schneider, MPH; Wei Zhao, MPH; et al.
JAMA. 2013;310(22):2435-2442. doi:10.1001/jama.2013.280490.
Includes: Supplemental Content

JAMA Clinical Challenge | 
Liran Levin, DMD; Liat Luder, RDH
JAMA. 2013;310(20):2195-2196. doi:10.1001/jama.2013.282405.

Editorial | 
Allan S. Brett, MD
JAMA. 2013;310(20):2151-2153. doi:10.1001/jama.2013.280501.

Clinical Trials Update | 
Anita Slomski
JAMA. 2013;310(20):2139. doi:10.1001/jama.2013.282477.

Original Investigation |  FREE
Björn Pasternak, MD, PhD; Henrik Svanström, MSc; Mads Melbye, MD, DrMedSci; et al.
JAMA. 2013;310(20):2184-2190. doi:10.1001/jama.2013.280500.
Includes: Supplemental Content

Editorial | 
Anne R. Cappola, MD, ScM
JAMA. 2013;310(17):1805-1806. doi:10.1001/jama.2013.280387.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(17):1784. doi:10.1001/jama.2013.281868.

Original Investigation |  FREE
Rebecca Vigen, MD, MSCS; Colin I. O’Donnell, MS; Anna E. Barón, PhD; et al.
JAMA. 2013;310(17):1829-1836. doi:10.1001/jama.2013.280386.
Includes: Supplemental Content

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(16):1666. doi:10.1001/jama.2013.281116.

Comment & Response | 
Russell K. Portenoy, MD
JAMA. 2013;310(16):1738. doi:10.1001/jama.2013.277291.

Comment & Response | 
Marcin Chwistek, MD
JAMA. 2013;310(16):1737. doi:10.1001/jama.2013.277305.

Comment & Response | 
Deborah Dowell, MD, MPH; Hillary V. Kunins, MD, MPH, MS; Thomas A. Farley, MD, MPH
JAMA. 2013;310(16):1738-1739. doi:10.1001/jama.2013.277320.

Medical News & Perspectives | 
Mike Mitka, MSJ
JAMA. 2013;310(16):1664. doi:10.1001/jama.2013.281115.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Original Investigation  | 
Changes in Glomerular Kidney Function Among HIV-1Uninfected Men and Women Receiving EmtricitabineTenofovir Disoproxil Fumarate Preexposure Prophylaxis:  A Randomized Clinical Trial
Kenneth K. Mugwanya, MBChB, MS; Christina Wyatt, MD, MS; Connie Celum, MD, MPH; et al.
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.